TEXAS HEALTHCARE AND BIOSCIENCE INSTITUTE ANNOUNCES SESSION TOPICS AT INAUGURAL STATEWIDE HEALTHCARE AND BIOSCIENCE SUMMIT

THBI is hosting this Texas-focused summit to serve as a precursor exploring how Texas plans to position itself as an industry leader both nationally and globally over the next decade and become recognized as the "Third Coast in Biotechnology".

Texas to Become Third Coast in Biotechnology

AUSTIN, TX – The Texas Healthcare and Bioscience Institute (THBI) announced the schedule of topics for its inaugural statewide Texas Healthcare and Bioscience Summit, taking place in Austin, Texas, on June 4-5, 2014, chaired by Health and Human Services Commissioner, Dr. Kyle Janek.

While many stakeholders in the bioscience industry have the BIO International Convention in San Diego already on their calendars; as a separate, regional event, THBI is hosting this Texas-focused summit to serve as a precursor exploring how Texas plans to position itself as an industry leader both nationally and globally over the next decade and become recognized as the “Third Coast in Biotechnology”.

Highly esteemed industry leaders and legislators are coming together to present a robust schedule of key topics impacting researchers, businesses, investors, and legislators. Sessions include:

• “A 6-month Check Up on the Affordable Care Act’s Impact on Texas” – Panelists include: Tara Ryan, PhRMA; John Zerwas, M.D., Texas State Representative; David Gonzales, Texas Association of Health Plans; Chris Traylor, Health and Human Services Commission. 
• “The State’s Role in Attracting and Building Biotech Investment Opportunities” – Moderated by: Jacqueline Northcut, BioHouston. Panelists include: Kevin Lalande, Sante Ventures; Evan Melrose, M.D., Spindletop Capital; Dan Watkins, PhD, Mercury Fund; Rick Anderson, PTV Sciences.
• “Regional Insights for Statewide Progress” – Moderated by: Tom Kowalski, THBI. Panelists include: Jacqueline Northcut, BioHouston; Bruce Leander, BioAustin; Ann Stevens, BioMed San Antonio; Todd McDaniel, The Research Valley Partnership; Jack Hart, Temple Health & Bioscience District.
• “Establishing the Third Coast in Biotechnology: Government, Industry, Reinvention of the Academic Health Science Center” – Presented by: Brett Giroir, M.D., Executive Vice President and CEO, Texas A&M University Health Science Center.
• “How Texas Fits into the Big Picture” – Moderated by: Tom Kowalski, THBI. Panelists include: James Greenwood, President and CEO, BIO; John Castellani, President and CEO, PhRMA.
• “Cancer Moon Shot Program: Creating a Robust Translational Pipeline” – Presented by: Ronald DePinho, M.D., President of MD Anderson Cancer Center.
• “The Future of Medicaid” – Moderated by: Billy Millwee, Millwee Consulting. Panelists include: Cindy Mann, Center for Medicare and Medicaid Services; Kyle Janek, M.D., Health and Human Services Commission.
• “Payment Reform and New Models of Care” – Panelists include: Steve Conti, Seton; Robert Popovian, PharmD, Pfizer; Guy Clifton, M.D., University of Texas Medical School at Houston.
• “A Conversation on Biosimilars and the Future of Healthcare Innovation in Texas” – A conversation with Fritz Bittenbender, BIO.

 

On Wednesday evening, June 4^th, THBI will honor Texas House of Representatives Speaker Joe Straus for his impact in the field, supporting legislation that fosters medical advancements through research, development and innovation. Joel Allison, CEO, Baylor Health Care System and Baylor Scott & White Health, serves as the keynote speaker.

“THBI is, and always has been, the leading public policy voice for this industry in Texas,” says Tom Kowalski, President and CEO of THBI. “Currently there is no statewide conference quite like this and we are excited to be able to host it; it is a natural fit for us.”

The Texas Healthcare and Bioscience Summit will take place at the Renaissance Hotel in North Austin. Tickets are $325 for the summit and $100 for the Luminary Dinner. To register, go to www.thbi.com and click on the event logo.

About THBI

The Texas Healthcare and Bioscience Institute (THBI) is the leading voice for the healthcare and bioscience industry in the state of Texas. Among its many efforts, THBI works to promote effective government legislation at the state and federal levels. Membership consists of pharmaceutical companies, academic institutions, medical device companies, and economic development entities, providing unparalleled networking to effectively address the needs of Texas’ growing life science community. The Texas Healthcare and Bioscience Institute is a nonprofit 501(c)(6) organization. www.thbi.com

Media Contact
Company Name: Texas Healthcare and Bioscience Institute
Contact Person: Patti D. Hill
Email:Send Email
Phone: 512-218-0401
City: Austin
State: Texas
Country: United States
Website: http://www.thbi.com
Source: www.abnewswire.com